Literature DB >> 7449818

Evidence of an involvement of the opioid peptidergic system in the reaction to stressful conditions.

R Arrigo-Reina, S Ferri.   

Abstract

Rats exposed to combined cold and restraint exhibited reduced paw oedema following an injection of carrageenin. Under the same experimental conditions, the local inflammation became fully evident when animals were pretreated with naloxone, 5 mg/kg, s.c. The same dose of the narcotic antagonist also increased the intensity of gastric damage in restrained, cold-exposed rats. On the contrary, gastric ulcerations were practically inexistent in stressed rats treated with 10 mg/kg s.c. of morphine. It is suggested that the opioid peptidergic system is involved in the body's reactivity to stressful stimuli.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7449818     DOI: 10.1016/0014-2999(80)90372-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Correlations between histamine and opioid peptides on the modulation of inflammatory processes in rats exposed to stress.

Authors:  R Arrigo-Reina
Journal:  Agents Actions       Date:  1988-04

2.  Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf.

Authors:  J V Esplugues; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

3.  Mechanism of intragastric nicotine protection against ethanol-induced gastric injury.

Authors:  K Endoh; M Baker; F W Leung
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

4.  Gastroduodenal bicarbonate secretion in mucosal protection. Possible role of vasoactive intestinal peptide and opiates.

Authors:  G Flemström; E Kivilaakso; S Briden; O Nylander; G Jedstedt
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

5.  Codeine added to paracetamol induced adverse effects but did not increase analgesia.

Authors:  P Skjelbred; P Løkken
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.